These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
279 related items for PubMed ID: 19414923
1. The pharmacokinetics of the lymphotropic nanoparticle MRI contrast agent ferumoxtran-10. Islam T, Wolf G. Cancer Biomark; 2009; 5(2):69-73. PubMed ID: 19414923 [Abstract] [Full Text] [Related]
2. Preoperative diagnosis of lymph node metastases in gastric cancer by magnetic resonance imaging with ferumoxtran-10. Tatsumi Y, Tanigawa N, Nishimura H, Nomura E, Mabuchi H, Matsuki M, Narabayashi I. Gastric Cancer; 2006; 9(2):120-8. PubMed ID: 16767368 [Abstract] [Full Text] [Related]
3. Ultrasmall superparamagnetic iron-oxide-enhanced MR imaging of normal bone marrow in rodents: original research original research. Simon GH, Raatschen HJ, Wendland MF, von Vopelius-Feldt J, Fu Y, Chen MH, Daldrup-Link HE. Acad Radiol; 2005 Sep; 12(9):1190-7. PubMed ID: 16099684 [Abstract] [Full Text] [Related]
4. Splenic imaging with ultrasmall superparamagnetic iron oxide ferumoxtran-10 (AMI-7227): preliminary observations. Harisinghani MG, Saini S, Weissleder R, Rubin D, deLange E, Harms S, Weinreb J, Small W, Sukerkar A, Brown JJ, Zelch J, Lucas M, Morris M, Hahn PF. J Comput Assist Tomogr; 2001 Sep; 25(5):770-6. PubMed ID: 11584239 [Abstract] [Full Text] [Related]
5. USPIO (Ferumoxtran-10)-enhanced MRI to visualize reticuloendothelial system cells in neonatal rats: feasibility and biodistribution study. Azoulay R, Olivier P, Baud O, Verney C, Santus R, Robert P, Gressens P, Sebag G. J Magn Reson Imaging; 2008 Oct; 28(4):1046-52. PubMed ID: 18821607 [Abstract] [Full Text] [Related]
6. Overview of nanoparticle use in cancer imaging. Islam T, Harisinghani MG. Cancer Biomark; 2009 Oct; 5(2):61-7. PubMed ID: 19414922 [Abstract] [Full Text] [Related]
13. Preclinical safety and pharmacokinetic profile of ferumoxtran-10, an ultrasmall superparamagnetic iron oxide magnetic resonance contrast agent. Bourrinet P, Bengele HH, Bonnemain B, Dencausse A, Idee JM, Jacobs PM, Lewis JM. Invest Radiol; 2006 Mar; 41(3):313-24. PubMed ID: 16481915 [Abstract] [Full Text] [Related]
15. Ferumoxtran-10, a superparamagnetic iron oxide as a magnetic resonance enhancement agent for imaging lymph nodes: a phase 2 dose study. Hudgins PA, Anzai Y, Morris MR, Lucas MA. AJNR Am J Neuroradiol; 2002 Apr; 23(4):649-56. PubMed ID: 11950660 [Abstract] [Full Text] [Related]